ArticleFrontiers in immunology2022

Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets.

Zahra Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.